Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 15 of 256 for:    "methodist hospital" | Recruiting, Not yet recruiting, Available Studies | Houston

Stroke Recovery and Music or No Music

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03608904
Recruitment Status : Recruiting
First Posted : August 1, 2018
Last Update Posted : August 1, 2018
Sponsor:
Collaborator:
Houston Methodist Centers of Performing Arts Medicine
Information provided by (Responsible Party):
John J. Volpi, MD, The Methodist Hospital System

Brief Summary:
The primary outcome of this study is to determine the quantitative increase in connectivity, as measured by fMRI brain and calculated as a percent increase from baseline in patients with ischemic stroke. Eligible patients will receive a listening session of music or spoken word listening, 30 days to 5 years following ischemic stroke. Assessments will include modified Rankin Scale, National Institute of Health Stroke Scale, functional Magnetic Resonance Imaging, motor function tests, and neuropsychological evaluations. Assessments occur at baseline, day 45, and day 90 after starting listening sessions.

Condition or disease Intervention/treatment Phase
Ischemic Stroke Other: Music listening Other: Spoken word (language) listening Not Applicable

Detailed Description:

This is a prospective, investigator-blinded and outcome assessor-blinded, randomized, single-center study in subjects 18-90 years old who have sustained an ischemic stroke within 30 days to 5 years. Study subjects will be randomized 1:1 to receive one of two types of listening sessions: music or spoken word (language) listening. Each arm will enroll a total of ten subjects, with a total study population of 20 subjects. Subjects will follow a 90-day listening schedule.

Subjects will complete a baseline Montreal Cognitive Assessment (MoCA), National Institute of Health Stroke Scale (NIHSS), modified Rankin Score (mRS), motor function tests, neuropsychological evaluations and functional magnetic resonance imaging (fMRI) brain evaluation. Follow-up evaluations on day 45 (+/- 7 days) and on day 90 (+/-7days) and will include NIHSS/mRS, motor function tests, neuropsychological evaluations and fMRI Brain evaluation.

All subjects will continue to receive standard of care treatment for stroke as directed by their physician(s) regardless of study enrollment.

The primary objective is to determine the quantitative increase in connectivity, as measured by fMRI brain and calculated as a percent increase from baseline.

The secondary objectives include the effect of music and language listening in improving motor function and neuropsychological development in patients with an ischemic stroke.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Participants will be exposed to music or no music (spoken words only) during their fMRI scans.
Masking: Double (Investigator, Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: A Quantitative Connectivity Assessment of Music Listening Compared to Spoken Word in Ischemic Stroke Recovery, as Measured by Functional MRI (fMRI).
Actual Study Start Date : July 21, 2017
Estimated Primary Completion Date : December 31, 2019
Estimated Study Completion Date : December 31, 2019

Arm Intervention/treatment
Experimental: Music Listening
Familiar and unfamiliar music selections, listening duration of approximately 15 minutes, three times daily, 90-day listening duration.
Other: Music listening
Familiar and unfamiliar music selections, listening duration of approximately 15 minutes, three times daily, 90-day listening duration.

Placebo Comparator: Spoken word (language) listening
Familiar and unfamiliar spoken word (language) selections, listening duration of approximately 15 minutes, three times daily, 90-day listening duration.
Other: Spoken word (language) listening
Familiar and unfamiliar spoken word (language) selections, listening duration of approximately 15 minutes, three times daily, 90-day listening duration.




Primary Outcome Measures :
  1. Change in Connectivity as Measured by Functional Magnetic Resonance Imaging (fMRI) at Baseline as Compared to Post-Listening Exposure at Days 45 and 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To determine quantitative increase in connectivity of music and/or spoken word (language) listening, as measured by fMRI brain, and calculated as a percent increase from baseline.


Secondary Outcome Measures :
  1. Change in Motor Function Test Pinch Grip (pounds) at Baseline as Compared to Post-Listening Exposure at Day 45 and Day 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To assess the effect of music and/or spoken word (language) listening in improving motor function test of pinch grip.

  2. Change in Motor Function Test Grip Strength (pounds) at Baseline as Compared to Post-Listening Exposure at Days 45 and 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To assess the effect of music and/or spoken word (language) listening in improving motor function test of grip strength.

  3. Change in Grooved Pegboard Test (seconds) at Baseline as Compared to Post-Listening Exposure at Days 45 and 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To assess the effect of music and/or spoken word (language) listening in improving motor function test of grooved pegboard test.

  4. Change in Action Research Arm Test (score) at Baseline as Compared to Post-Listening Exposure at Days 45 and 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To assess the effect of music and/or spoken word (language) listening in improving motor function test of Action Research Arm Test (ARAT).

  5. Change in Timed Up and Go (seconds) at Baseline as Compared to Post-Listening Exposure at Days 45 and 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To assess the effect of music and/or spoken word (language) listening in improving motor function test of Timed Up and Go.

  6. Change in 10 Meter Walk Test (seconds) at Baseline as Compared to Post-Listening Exposure at Days 45 and 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To assess the effect of music and/or spoken word (language) listening in improving motor function test of 10 meter walk test.

  7. Change in Modified Rankin Score (score) at Baseline as Compared to Post-Listening Exposure at Days 45 and 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To assess the effect of music and/or spoken word (language) listening in improvement of disability score.

  8. Change in National Institutes of Health Stroke Scale (score) at Baseline as Compared to Post-Listening Exposure at Days 45 and 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To assess the effect of music and/or spoken word (language) listening in improvement of standardized stroke score.

  9. Change in Neuropsychological Evaluation Wechsler Adult Intelligence Scale-IV: Digit Span (score) at Baseline as Compared to Post-Listening Exposure at Days 45 and 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To assess the effect of music and/or spoken word (language) listening in improvements of neuropsychology evaluation of an aural test of immediate attention and working memory.

  10. Change in Neuropsychological Evaluation Albert's Test (score) at Baseline as Compared to Post-Listening Exposure at Days 45 and 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To assess the effect of music and/or spoken word (language) listening in improvement of neuropsychology evaluation of a line cancellation test of visual attention/neglect.

  11. Change in Neuropsychological Evaluation Rey Complex Figure Test and Recognition Trial (score) at Baseline as Compared to Post-Listening Exposure at Days 45 and 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To assess the effect of music and/or spoken word (language) listening in improvement of neuropsychology evaluation of a drawing test used to assess planning, organization and visual-spatial skills.

  12. Change in Neuropsychological Evaluation MAST (score) at Baseline as Compared to Post-Listening Exposure at Days 45 and 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To assess the effect of music and/or spoken word (language) listening in improvement of neuropsychology evaluation of a language measure for patients with aphasia.

  13. Change in Neuropsychological Evaluation MAE Token Test (score) at Baseline as Compared to Post-Listening Exposure at Days 45 and 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To assess the effect of music and/or spoken word (language) listening in improvement of neuropsychology evaluation of an aural language comprehension measure.

  14. Change in Neuropsychological Evaluation Boston Naming Test (score) at Baseline as Compared to Post-Listening Exposure at Days 45 and 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To assess the effect of music and/or spoken word (language) listening in improvement of neuropsychology evaluation of a test of confrontation naming.

  15. Change in Neuropsychological Evaluation Phonemic Fluency (score) at Baseline as Compared to Post-Listening Exposure at Days 45 and 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To assess the effect of music and/or spoken word (language) listening in improvement of neuropsychology evaluation of a generative naming test.

  16. Change in Neuropsychological Evaluation Semantic fluency (score) at Baseline as Compared to Post-Listening Exposure at Days 45 and 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To assess the effect of music and/or spoken word (language) listening in improvement of neuropsychology evaluation of a generative naming test.

  17. Change in Neuropsychological Evaluation Wide Range Achievement Test-4 Reading (score) at Baseline as Compared to Post-Listening Exposure at Days 45 and 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To assess the effect of music and/or spoken word (language) listening in improvement of neuropsychology evaluation of a single-word reading measure that can be used, in some, to assess premorbid intellectual abilities.

  18. Change in Neuropsychological Evaluation Trail Making Test-A (score) at Baseline as Compared to Post-Listening Exposure at Days 45 and 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To assess the effect of music and/or spoken word (language) listening in changes of a neuropsychology evaluation of a speeded psychomotor test of attention.

  19. Change in Neuropsychological Evaluation Trail Making Test-B (score) at Baseline as Compared to Post-Listening Exposure at Days 45 and 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To assess the effect of music and/or spoken word (language) listening in improvement of neuropsychology evaluation of a speeded psychomotor test of alternating attention/working memory.

  20. Change in Neuropsychological Evaluation Hopkins Verbal Learning Test-Revised (score) at Baseline as Compared to Post-Listening Exposure at Days 45 and 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To assess the effect of music and/or spoken word (language) listening in changes of a neuropsychology evaluation of a rote verbal learning and test.

  21. Change in Neuropsychological Evaluation Brief Visuospatial Memory Test-Revised (score) at Baseline as Compared to Post-Listening Exposure at Days 45 and 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To assess the effect of music and/or spoken word (language) listening in improvement of neuropsychology evaluation of a visual learning and memory test.

  22. Change in Neuropsychological Evaluation Clock Test (score) at Baseline as Compared to Post-Listening Exposure at Days 45 and 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To assess the effect of music and/or spoken word (language) listening in improvement of neuropsychology evaluation of a measure of conceptualization, planning, organization, and visual-spatial skills.

  23. Change in Neuropsychological Evaluation Beck Depression Inventory-II (score) at Baseline as Compared to Post-Listening Exposure at Days 45 and 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To assess the effect of music and/or spoken word (language) listening in improvement of neuropsychology evaluation of a test to measure depression.

  24. Change in Neuropsychological Evaluation Generalized Anxiety Disorder 7-item(score) at Baseline as Compared to Post-Listening Exposure at Days 45 and 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To assess the effect of music and/or spoken word (language) listening in improvement of neuropsychology evaluation of a test to measure generalized anxiety.

  25. Change in Neuropsychological Evaluation The Stroke-Adapted Sickness Impact Profile (SA-SIP30) (score) at Baseline as Compared to Post-Listening Exposure at Days 45 and 90. [ Time Frame: Change from Baseline to Days 45 and 90 ]
    To assess the effect of music and/or spoken word (language) listening in improvement of neuropsychology evaluation of a post-stroke quality of life measure.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Ischemic Stroke 30 days to 5 years days prior to enrollment
  2. Age 18-90
  3. Modified Rankin Score (mRS) 1-3, inclusive, post-qualifying event (for a history of multiple strokes, baseline mRS is 0-1 AND a lower value than the qualifying mRS)
  4. A measureable deficit either in motor or speech/cognition that can be assessed using standardized testing
  5. Fluency in English (written and verbal)
  6. Demonstrates willingness to participate in study and complete all schedule of events

Exclusion Criteria:

  1. Severe cognitive impairment, as determined by investigator using the baseline MoCA score
  2. Comorbid neurological disease that may interfere with rehabilitation
  3. Psychiatric disorder or taking psychoactive medication that may interfere with completing study
  4. Inability to complete music listening exercises
  5. Alcohol or drug abuse
  6. Hearing impairment
  7. Contraindication to scheduled fMRI Brain evaluations
  8. Pregnant women

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03608904


Contacts
Layout table for location contacts
Contact: Jonathan Wiese, MSN, RN 713-441-7161 jrwiese@houstonmethodist.org
Contact: Paige McIntyre 713-363-9052 pmcintyre@houstonmethodist.org

Locations
Layout table for location information
United States, Texas
Houston Methodist Recruiting
Houston, Texas, United States, 77030
Contact: John J Volpi, MD         
Sponsors and Collaborators
The Methodist Hospital System
Houston Methodist Centers of Performing Arts Medicine
Investigators
Layout table for investigator information
Principal Investigator: John J Volpi, MD Houston Methodist

Publications:
Layout table for additonal information
Responsible Party: John J. Volpi, MD, Principal Investigator, Neurologist, The Methodist Hospital System
ClinicalTrials.gov Identifier: NCT03608904     History of Changes
Other Study ID Numbers: Pro00015563
First Posted: August 1, 2018    Key Record Dates
Last Update Posted: August 1, 2018
Last Verified: July 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: No plans at to share individual subject data at this time.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by John J. Volpi, MD, The Methodist Hospital System:
Stroke
Music
Ischemic Stroke
fMRI
functional MRI

Additional relevant MeSH terms:
Layout table for MeSH terms
Stroke
Ischemia
Cerebral Infarction
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Pathologic Processes
Brain Infarction
Brain Ischemia